Chemesis Partnership Expands Puerto Rico Footprint, Production Capacity; Plus Exclusive Interview with Board Member Deepak Anand
Tony Deyes
May 9th, 2019
App, Exclusive, News, Top News
Chemesis International Inc. (CSE: CSI, OTC: CADMF, FRA: CWAA) is gearing up for the legalization of hemp in Puerto Rico with a recently-announced partnership with First Medical Cannabis LLC, bolstering its presence on the island and enabling it to cultivate high-yield hemp-derived CBD on an industrial scale for local distribution as well as to the US mainland.
First Medical Cannabis is the largest private provider in Puerto Rico, which currently has 75 open dispensaries serving 65,000 patients. That number is predicted to grow to well over 100,000 by December and into a $100-150 million annual industry.
Commenting on the strategic partnership, Chemesis CEO, Edgar Montero said, “Chemesis is very excited to continue growing the market in Puerto Rico as the value of P.R. as a hub is very promising. We expect the industry to grow exponentially and Chemesis will be set-up at the forefront to succeed.”
Changing Landscape
The CBD market is already growing at a rate much faster than any other aspect of the cannabis market, and the hemp-derived CBD market is forecast to be especially lucrative.
Prior to the US Farm Bill earlier this year, the US was the only industrialized country with a ban on industrial hemp, putting hemp-dependent companies under its jurisdiction at a distinct disadvantage. The adoption of the legislation will enable the cultivation of industrial hemp crops, and address the current shortage of CBD. As a result, new Puerto Rican regulations allow licensed facilities to incorporate hemp-derived CBD products in to their portfolios so long as they are entered into its tracking system and tested by licensed labs located in Puerto Rico.
Competitive Advantages
First Medical controls one of the largest privately-owned land estates in the Valley de Lajas, one of the most agriculturally-prolific regions in the Caribbean due to its ideal climate, fertile soil, and a geographical location which allows for a much longer growing season. The partnership is expected to produce multiple hemp crops annually, create hundreds of jobs, and bolster economic development in Lajas.
“Since the last of Puerto Rico’s sugar mills closed in 2000, the island has been in need of an agricultural revolution and the hemp industry promises much needed jobs,” Montero added. “Puerto Rico’s tropical climate makes the island an ideal competitor in the hemp industry. Furthermore, it will allow the Company to harvest up to three crops per year compared to one in many areas around the world.”
Chemesis will have immediate access to 1,000 acres for hemp cultivation, with the option to expand up to an additional 5,000 acres of prime agricultural land. Chemesis’ fully-compliant Puerto Rican extraction & manufacturing facility has the capacity to off-take all hemp produced by First Medical, process it into finished goods, and distribute them locally and to the continental US.
Montero continued, “As previously announced, the company has begun cultivating high potency CBD strains and will leverage its licenses and registered seed strains to develop high quality crops. With the passing of the 2018 Farm Bill, Chemesis has acquired the necessary assets and built strategic relationships which will allow the company to cultivate, manufacture, and ship finished goods across the United States.”
Chemesis plans to examine additional uses of industrial hemp such as a development of hemp bio-diesel to further diversify its offering.
Update on Colombian Operations
Puerto Rico isn’t Chemesis’ only regional presence; due to its own ideal growing conditions, low input costs, and the only Latin American government actively supporting the export of cannabis, Colombia is expected to become the hub of the red-hot emerging market.
In March, Chemesis’ wholly-owned Colombian subsidiary, La Finca Interacviva-Arachna Med, commenced large-scale cultivation after being awarded its seed producers license in January, the license enables the company to develop its own genetics catalogue as well as export high concentrate CBD genetics, distillates, and other manufactured products. The initial harvest is scheduled for Q2 2019 and La Finca is poised for expansion into large scale commercialization by Q4, having accumulated over 1,060 acres through its farming co-op.
La Finca is a founding member of Colombia’s Association for the Promotion of Hemp Growing, has established relationships with over 2,000 farming families throughout the country, and is involved in farmer education programs across the country. It has also partnered with Colombia’s largest university for research & development.
La Finca is proceeding with agronomic evaluations required by the Colombian Ministry of Agriculture to increase the number of cultivars it can use to achieve commercialization in all regions and climates across Colombia. It is currently licensed for five cultivars which will be harvested for domestic and international distribution, each one developed with the Universidad Nacional de Colombia using selective breeding methods to ensure each plant variety was developed to leverage Colombia’s climate while obtaining the highest quality and yields.
Montero said, “This is a significant step forward for Chemesis and the team in Colombia. The Seed Producer License not only allows the company to grow and harvest, but import and export cannabis derivatives and seeds. The Chemesis team has been working very hard to see our long-term vision take shape, and we see the ability to commercialize worldwide as a significant step forward.”
La Finca currently offers cannabinoid-based cosmetic products and is continuing to expand its product lines as the company grows. Through La Finca, Chemesis also controls a 10,000 sq. ft. greenhouse and is currently building a GMP-certified production lab and extraction facility in Bogota to supply the Colombian market as well as support export opportunities.
Chemesis’ close relationships with industry and political leaders have positioned it as a strategic first-mover in Colombia, Puerto Rico, as well as California, giving it a distinct advantage over much of its competition.
For more information, keep watching this page or visit https://chemesis.com/
And connect with Chemesis in social media:
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Tony Deyes
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Technical420 is the premier provider of research and analysis on cannabis stocks. We provide investors with sponsored and non-sponsored information on the volatile and emerging cannabis industry. “Our research is our passion!” Your profit is our reward!
The producers of O’ Cannabiz have decades of experience producing national-profile events and creating global connections between business communities in the arts, broadcasting, media and technology. They have organized trade summit initiatives with governments around the world. And they have worked closely with sponsors in all levels of Canadian government.
The Gluu is the first ever distribution platform serving the larger cannabis industry, linking together suppliers, manufacturers, reps, retailers and customers. If you sell products think of us as the B2B Amazon of the industry.
CanIDeal is the first fully-legal, B2B digital marketplace for the entire cannabis industry. The company’s mission is to provide an easy-to-use and safe ecommerce solution for entrepreneurs in the market for THC, CBD and ancillary products.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
